Common Stock, Shares, Outstanding of Panbela Therapeutics, Inc. from 31 Dec 2011 to 30 Sep 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Panbela Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2011 to 30 Sep 2024.
  • Panbela Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2024 was 4,854,861, a 62% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Panbela Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 4,854,861 +1,858,527 +62% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 4,854,861 +2,242,823 +86% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 4,854,861 -11,234,455 -70% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 480,025 +478,287 31 Dec 2023 10-Q 14 Nov 2024 2024 Q3
Q3 2023 2,996,334 -17,793,628 -86% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 2,612,038 -18,162,007 -87% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 16,089,316 +2,640,199 +20% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 1,738* -334,223 31 Dec 2022 10-K 26 Mar 2024 2023 FY
Q3 2022 20,789,962 +7,355,810 +55% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 20,774,045 +10,678,622 +106% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 13,449,117 +3,360,245 +33% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 335,961 -9,328,466 -97% 31 Dec 2021 10-K 16 Mar 2023 2022 FY
Q3 2021 13,434,152 +3,784,725 +39% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 10,095,423 +3,027,122 +43% 30 Jun 2021 10-Q 11 Aug 2021 2021 Q2
Q1 2021 10,088,872 +3,457,564 +52% 31 Mar 2021 10-Q 12 May 2021 2021 Q1
Q4 2020 9,664,427 +3,033,119 +46% 31 Dec 2020 10-K 24 Mar 2022 2021 FY
Q3 2020 9,649,427 +3,025,261 +46% 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 7,068,301 +1,346,202 +24% 30 Jun 2020 10-Q 11 Aug 2020 2020 Q2
Q1 2020 6,631,308 +1,560,967 +31% 31 Mar 2020 10-Q 12 May 2020 2020 Q1
Q4 2019 6,631,308 +1,553,825 +31% 31 Dec 2019 10-K 25 Mar 2021 2020 FY
Q3 2019 6,624,166 +1,563,572 +31% 30 Sep 2019 10-Q 13 Nov 2019 2019 Q3
Q2 2019 5,722,099 +661,505 +13% 30 Jun 2019 10-Q 13 Aug 2019 2019 Q2
Q1 2019 5,070,341 +976,489 +24% 31 Mar 2019 10-Q 14 May 2019 2019 Q1
Q4 2018 5,077,483 +1,235,831 +32% 31 Dec 2018 10-K 24 Mar 2020 2019 FY
Q3 2018 5,060,594 +1,390,151 +38% 30 Sep 2018 10-Q 05 Nov 2018 2018 Q3
Q2 2018 5,060,594 -31,644,045 -86% 30 Jun 2018 10-Q 13 Aug 2018 2018 Q2
Q1 2018 4,093,852 -32,340,787 -89% 31 Mar 2018 10-Q 14 May 2018 2018 Q1
Q4 2017 3,841,652 +621,552 +19% 31 Dec 2017 10-K 22 Mar 2019 2018 FY
Q3 2017 3,670,443 -28,480,863 -89% 30 Sep 2017 10-Q 14 Nov 2017 2017 Q3
Q2 2017 36,704,639 +4,823,333 +15% 30 Jun 2017 10-Q 10 Aug 2017 2017 Q2
Q1 2017 36,434,639 +6,504,333 +22% 31 Mar 2017 10-Q 11 May 2017 2017 Q1
Q4 2016 3,220,100 -26,672,706 -89% 31 Dec 2016 10-K 21 Mar 2018 2017 FY
Q3 2016 32,151,306 +2,258,500 +7.6% 30 Sep 2016 10-Q 10 Nov 2016 2016 Q3
Q2 2016 31,881,306 +30,430,984 +2098% 30 Jun 2016 10-Q 11 Aug 2016 2016 Q2
Q1 2016 29,930,306 +28,479,984 +1964% 31 Mar 2016 10-Q 12 May 2016 2016 Q1
Q4 2015 29,892,806 +24,203,879 +425% 31 Dec 2015 10-K 30 Mar 2017 2016 FY
Q3 2015 29,892,806 +28,442,484 +1961% 30 Sep 2015 10-Q 16 Nov 2015 2015 Q3
Q2 2015 1,450,322 0 0% 30 Jun 2015 10-Q 13 Aug 2015 2015 Q2
Q1 2015 1,450,322 0 0% 31 Mar 2015 10-Q 15 May 2015 2015 Q1
Q4 2014 5,688,927 +4,238,605 +292% 31 Dec 2014 10-K 08 Mar 2016 2015 FY
Q3 2014 1,450,322 0 0% 30 Sep 2014 10-Q 14 Nov 2014 2014 Q3
Q2 2014 1,450,322 0 0% 30 Jun 2014 10-Q 14 Aug 2014 2014 Q2
Q1 2014 1,450,322 0 0% 31 Mar 2014 10-Q 15 May 2014 2014 Q1
Q4 2013 1,450,322 0 0% 31 Dec 2013 10-K 30 Mar 2015 2014 FY
Q3 2013 1,450,322 30 Sep 2013 10-Q 14 Nov 2013 2013 Q3
Q2 2013 1,450,322 30 Jun 2013 10-Q 14 Aug 2013 2013 Q2
Q1 2013 1,450,322 31 Mar 2013 10-Q 15 May 2013 2013 Q1
Q4 2012 1,450,322 0 0% 31 Dec 2012 10-K 28 Mar 2014 2013 FY
Q4 2011 1,450,322 31 Dec 2011 10-K 26 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.